

2011
- Nagaoka I, Igarashi M, Hua J, Yomogida S, Sakamoto K: Anti-platelet and anti-atherosclerotic actions of glucosamine hydrochloride. Glucosamine Res 7, Edited by Kaneko K, Nagaoka I, Okumura M, Nakamura H, Nomura Y, Wada M, Minami S. pp. 27-34, 2011 (Japanese)
- Igarashi M, Saiki A, Sakamoto K, Nagaoka I: Effect of glucosamine derivative on osteoblastic cell differentiation. Glucosamine Res 7, Edited by Kaneko K, Nagaoka I, Okumura M, Nakamura H, Nomura Y, Wada M, Minami S. pp. 40-44, 2011 (Japanese)
- Nagaoka I, Nakasone Y, Watanabe K, Yamamoto T, Watanabe K, Tomonaga A, Yamaguchi H: Effect of a dietary supplement containing glucosamine hydrochloride produced from microbes on the symptoms and cartilage biomarkers in individuals with knee pain. Glucosamine Res 7, Edited by Kaneko K, Nagaoka I, Okumura M, Nakamura H, Nomura Y, Wada M, Minami S. pp. 77-84, 2011 (Japanese)
- Nagaoka I, Igarashi M, Hua J, Ju Y, Yomogida S, Sakamoto K: Recent aspects of the anti-inflammatory actions of glucosamine. Carbohydrate Polymers 84, Edited by Chen R-H, Domard A, Muzzarelli R A A, Tokura S, Wang D-W. pp. 825-830, 2011.

2010
- Katoh A, Morita H, Harada H, Shiotani E, Sakamoto K, Ikeda H: Beneficial effects of glucosamine hydrochloride on vascular endothelial function. Glucosamine Res 6, Edited by Nomura Y, Nagaoka I, Nakamura H, Wada M, Minami S. pp. 55-60, 2010 (Japanese)
- Katsuno S, Sato K, Eguchi C, Yoshimura K, Yamamoto T, Tomonaga A, Nagaoka I: Study for clinical effects of milk beverage containing N-acetylglucosamine on knee joint pain and biomarkers of cartilage metabolism. Glucosamine Res 6, Edited by Nomura Y, Nagaoka I, Nakamura H, Wada M, Minami S. pp. 44-54, 2010 (Japanese)
- Igarashi M, Kaga I, Hua J, Takamori M, Sakamoto K, Miyazawa K, Nagaoka I: Effect of amino monosaccharides and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes; second report. Glucosamine Res 6, Edited by Nomura Y, Nagaoka I, Nakamura H, Wada M, Minami S. pp. 68-71, 2010 (Japanese)

2009
- Nagaoka I, Yoshimura M, Sakamoto K, Tsuruta A, Yamamoto T, Ishida K, Yamaguchi H: Evaluation of the effects of glucosamine administration on joint (cartilage and bone) biomarkers. Glucosamine Res 5, Edited by Nakamura H, Nagaoka I, Nomura Y, Wada M, Minami S. pp. 32-40, 2009 (Japanese)
- Igarashi M, Kaga I, Hua J, Takamori M, Sakamoto K, Miyazawa K, Nagaoka I: Effect of amino monosaccharides and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes. Glucosamine Res 5, Edited by Nakamura H, Nagaoka I, Nomura Y, Wada M, Minami S. pp. 55-60, 2009 (Japanese)

2008
- Naito K, Watari T, Yomogida S, Nagaoka I, Sakamoto, Yamaguchi H, Kurosawa H, Kaneko K: Evaluation of the effect of glucosamine treatment on osteoarthritis using biochemical markers. Glucosamine Res 4, Edited by Minami S, Nagaoka I, Nakamura H, Nomura H, Wada M. pp. 9-15, 2008 (Japanese)
- Nagaoka I, Hua J, Ju Y, Yomogida S, Sakamoto K: Recent aspects of the biological activities of glucosamine hydrochloride. Glucosamine Res 4, Edited by Minami S, Nagaoka I, Nakamura H, Nomura H, Wada M. pp. 16-27, 2008 (Japanese)

2007
- Maeda H, Uehara A, Saito T, Mayanagi H, Nagaoka I, Takada H: An antibacterial protein CAP18/LL-37 enhanced production of hepatocyte growth factor in human gingival fibroblast cultures. Interface Oral Health Science, Edited by Watanabe, M., Okuno, O. pp. 283-284, 2007
- Ju Y, Hua J, Sakamoto K, Nagaoka I: Effects of glucosamine on endothelial cell functions. Glucosamin Res 3, Edited by Nagaoka I, Nakamura H, Nomura H, Minami S, Wada M. pp. 12-18, 2007 (Japanese)
- Nagaoka I: Cellular function of glucosamine. Glucosamin Res 3, Edited by Nagaoka I, Nakamura H, Nomura H, Minami S, Wada M. pp. 74-79, 2007 (Japanese)

2006
- Nagaoka I, Hua J, Yomogida S, Tsutsumi-Ishii Y, Sakamoto K: Anti-inflammatory and anti-platelet actions of glucosamine. Advance in Chitin Science Vol. IX, Edited by Domard A,Guibal E, Vårum KM. pp. 326-332, 2006.

2004
- Nagaoka I, Hua J, Suguro S, Sakamoto K: Glucosamine, a novel anti-platelet agent for thrombotic disorders, which suppresses platelet functions. Advance in Chitin Science Vol. VII, Boucher I, Jamieson K, Retnakaran A (eds), 31-36, 2004. [Abstract]

2000
- Iwabuchi K, Handa K, Hakomori SI: Separation of glycosphingolipid-enriched microdomains from caveolar membrane characterized by presence of caveolin. Sphingolipid metabolism and cell signaling, Part B In: Methods in Enzymology. Vol. 312, Abelson JN, Simon MI (eds), 488-494, Academic Press, San Diego, 2000. [PubMed]
- Megidish T, Hamaguchi A, Iwabuchi K, Hakomori SI: Assays of sphingosine-dependent kinase for 14-3-3 protein. Sphingolipid metabolism and cell signaling, Part B In: Methods in Enzymology. Vol. 312, Abelson JN, Simon MI (eds), 381-387, Academic Press, San Diego, 2000.[PubMed]